Early change in the clearance of pembrolizumab reflects the survival and therapeutic response: A population pharmacokinetic analysis in real-world non-small cell lung cancer patients.
暂无分享，去创建一个
Y. Ohe | N. Yamamoto | H. Horinouchi | Y. Goto | Y. Okuma | A. Hamada | K. Akagi | Y. Makino | Tatsuya Yoshida | H. Jo | Y. Shinno | K. Masuda | S. Yagishita | Mayu Ohuchi | Ryoko Inaba Higashiyama | T. Yoshida